BRIEF-Mylan invalidates two of Teva's Copaxone patents
August 24, 2016 at 17:09 PM EDT
* Mylan invalidates two of Teva's Copaxone 40 mg/ml patents via U.S. Patent and Trademark Office's Inter Partes Review proceeding
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.